Xiaoyin Wang

Economic evaluation of the MEDENOX trial: a Canadian perspective. Medical Patients with Enoxaparin.

The effect of oxygenator membranes on blood: a comparison of two oxygenators in open-heart surgery.

Opening of Ca2+-activated K+ channels triggers early and delayed preconditioning against I/R injury independent of NOS in mice.

Bayesian inference on the patient population size given list mismatches.

Pharmacological preconditioning with sildenafil: Basic mechanisms and clinical implications.

Silencing heat shock factor 1 by small interfering RNA abrogates heat shock-induced cardioprotection against ischemia-reperfusion injury in mice.

The Canadian off-pump coronary artery bypass graft registry: a one-year prospective comparison with on-pump coronary artery bypass grafting.

Hypercholesterolemia enhances tolerance to lethal systemic hypoxia in middle-aged mice: possible role of VEGF downregulation in brain.

A cost comparison of off-pump CABG versus on-pump CABG at one-year: The Canadian off-pump CABG registry.

Early mortality from off-pump and on-pump coronary bypass surgery in Canada: a comparison of the STS and the EuroSCORE risk prediction algorithms.

Essential role of mitochondrial Ca2+-activated and ATP-sensitive K+ channels in sildenafil-induced late cardioprotection.

Cost comparison of ablation versus antiarrhythmic drugs as first-line therapy for atrial fibrillation: an economic evaluation of the RAAFT pilot study.

Endogenous microRNAs induced by heat-shock reduce myocardial infarction following ischemia-reperfusion in mice.

Cost comparison of four revascularisation procedures for the treatment of multivessel coronary artery disease: a commentary.

Cost comparison of four revascularisation procedures for the treatment of multivessel coronary artery disease.

Canadian Registry of ICD Implant Testing procedures (CREDIT): current practice, risks, and costs of intraoperative defibrillation testing.

Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences.

Donor myocardial infarction impairs the therapeutic potential of bone marrow cells by an interleukin-1-mediated inflammatory response.

The cost implications of the use of telmisartan or ramipril in patients at high risk for vascular events: the ONTARGET study.

Polymerase II promoter strength determines efficacy of microRNA adapted shRNAs.

Blunting half of the double-edged sword: potential use of interleukin-10 to protect bone marrow-derived cells after myocardial infarction.